Back to
Schonfeld Strategic Advisors LLC
QNCX
Showing 0 of 11 quarters
Position history for
Schonfeld Strategic Advisors LLC's holdings in QUINCE THERAPEUTICS INC
No. Schonfeld Strategic Advisors exited its QNCX (Quince Therapeutics) position in Q4 2022. Its Q3 2022 13F listed 27,300 shares worth $36,000. Schonfeld Strategic Advisors first reported QNCX in Q2 2019 and held it in 7 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.